ArticleThe Journal of investigative dermatology2017

Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea.

Jack C O'Brien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.